Jefferies Group LLC Zai Lab LTD Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $210,000 - $356,740	-2,000 Closed	0 $0
Q2 2021 Aug 20, 2021	SELL	$125.11 - $180.0 $24.8 Million - $35.6 Million	-198,000 Reduced 99.0%	2,000 $354,000
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $24.8 Million - $35.6 Million	198,000 Added 9900.0%	200,000 $354,000
Q1 2021 Sep 21, 2023	BUY	$126.27 - $191.71 $252,540 - $383,420	2,000 New	2,000 $266,000
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $252,540 - $383,420	2,000 New	2,000 $267,000

133

48.9M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.74B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.